13F Data
13F filer · CIK 1688325

TRV GP IV, LLC

Boston, MA · filing since Q4 2018 · last filing Aug 10, 2026
Reported value
$253.7M
$-13.2M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%

Biggest buys vs Q1 2026

No new or increased positions this quarter.

Biggest sells vs Q1 2026

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2018: $45.6MQ1 2019: $131.9MQ2 2019: $118.1MQ3 2019: $97.7MQ4 2019: $160.4MQ1 2020: $109.4MQ2 2020: $217.1MQ3 2020: $290.5MQ4 2020: $311.7MQ1 2021: $271.4MQ2 2021: $210.1MQ3 2021: $440.7MQ4 2021: $347.8MQ1 2022: $273.0MQ2 2022: $152.1MQ3 2022: $171.1MQ4 2022: $235.2MQ1 2023: $139.9MQ2 2023: $110.7MQ3 2023: $265.4MQ4 2023: $246.1MQ1 2024: $206.4MQ2 2024: $202.2MQ3 2024: $162.1MQ4 2024: $80.2MQ1 2025: $92.9MQ2 2025: $163.3MQ3 2025: $274.0MQ4 2025: $255.1MQ1 2026: $266.9MQ2 2026: $253.7M
Q4 2018Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1MAZE THERAPEUTICS, INC.COM4,473,958$133.5M52.63%
2TANGO THERAPEUTICS, INC.COM6,374,574$120.2M47.37%